Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
2/7/2024
I-Mab to Divest China Operations and Become a US-Focused Biotech
2/7/2024
NHC: China Continues to Improve Access to Public Medical Services
2/7/2024
Boao Lecheng Pilot Zone Experiments Expedited Entry into China's Healt...
2/7/2024
China's Basic Medical Insurance System Reports Revenue of CNY 2.7T in ...
2/7/2024
Review of Chinese Anti-tumor Hospital Drug Sales in 2023: Pharnexcloud
2/7/2024
Review and Outlook of China's Foreign Trade of Medicines and Health Pr...
2/7/2024
NMPA Restores Import, Sales and Use of GSK's BPH Drug
2/6/2024
NMPA and Chinese Customs Announce Addition of Hefei Airport as a Drug ...
2/6/2024
Potential Impact of the US Bill on Wuxi AppTec and Its Western Drugmak...
2/6/2024
Luye Pharma Collaborates with Myung In Pharm in Advancing Treatment f...
2/6/2024
Global Pharma Invests in China on the Strength of a Booming National B...
2/5/2024
Number of Pharmacists in China in 2022, by Region (Statista)
2/5/2024
Biotech Is the New Focus in U.S.-China Tech Rivalry (Axios)
2/5/2024
CMS Licenses Greater China Rights of First-line Phosphate-lowering Dru...
2/5/2024
NHSA Issues the Centralizd Drug Procurement Platform Service Guideline...
2/5/2024
U.S. Congress Postpones Legislation Targeting Chinese Biotech Firms
2/5/2024
Eisai Encouraged by Market Potential of Its Alzheimer's Drug Leqembi i...
2/2/2024
AmCham China's 26th Annual China Business Climate Survey: US Firms in ...
2/2/2024
Inmagene Exercises Option to License Two HutchMed Drug Candidates as P...
2/2/2024
Recent Official and Executive Moves
1/30/2024
China Expands Online Cross-Provincial Medical Bill Settlements
1/30/2024
NH Reports Latest Data on Chinese Smoking Control Market in MAT 09/202...
1/30/2024
2024 China Medtech Industry Outlook (Simon Kucher)
1/29/2024
Lonza to Close Biologics Plant in Guangzhou after Only Three Years of ...
1/29/2024
Proposed US Legislation Rattles Chinese Biopharma Cos amid National Se...
1/26/2024
China Introduces Plan for Pudong New Area's Pilot Comprehensive Reform
1/26/2024
Recent Official and Executive Moves
1/25/2024
Celltrion, China's WuXi Bolster Ties on ADC Partnership
1/25/2024
Glenmark Licenses Cancer Drug from China's Alphamab, 3D Med
1/25/2024
NHC Holds the 2024 National Primary Healthcare Work Conference
Page:
33
/
356
Total number of articles:
10656
:
[First]
[<<]
[31]
[32]
[33]
[34]
[35]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit